Twelve and twenty-four hours after intraperitoneal administration of thioac
etamide (200 mg/kg body weight) to rats, caspase-3 activity in the liver an
d plasma of the treated rats increased significantly compared with that of
the control group. These results demonstrated that thioacetamide caused apo
ptosis, which involved activation of caspase-3, although there may be a num
ber of pathways to apoptosis in the liver that may or may not involve the a
ctivation of this protein. The results also indicated that the activated ca
spase-3 was released in plasma along with glutamate-oxaloacetate transamina
se (GOT) by successive necrosis. This is the first study that shows an incr
ease of caspase-3 activity in plasma. (C) 1999 Elsevier Science Inc.